Fidler, M. J., Fhied, C. L., Roder, J., Basu, S., Sayidine, S., Fughhi, I., . . . Borgia, J. A. (2018). The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients. BMC Cancer.
Citação norma ChicagoFidler, Mary Jo, et al. "The Serum-based VeriStrat® Test Is Associated With Proinflammatory Reactants and Clinical Outcome in Non-small Cell Lung Cancer Patients." BMC Cancer 2018.
Citação norma MLAFidler, Mary Jo, et al. "The Serum-based VeriStrat® Test Is Associated With Proinflammatory Reactants and Clinical Outcome in Non-small Cell Lung Cancer Patients." BMC Cancer 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.